DETERMINATION OF ALOGLIPTIN BENZOATE AND METFORMIN HYDROCHLORIDE IN TABLET DOSAGE FORM BY SIMULTANEOUS EQUATION AND ABSORPTION RATIO METHOD

  • Dhanya B Sen Department of Pharmacy, Sumandeep Vidyapeeth University, Piparia, Waghodia, Vadodara 391760, Gujarat, India
  • Ashim Kumar Sen Department of Pharmacy, Sumandeep Vidyapeeth University, Piparia, Waghodia, Vadodara 391760, Gujarat, India
  • Aarti Zanwar Department of Pharmacy, Sumandeep Vidyapeeth University, Piparia, Waghodia, Vadodara 391760, Gujarat, India
  • R. Balaraman Department of Pharmacy, Sumandeep Vidyapeeth University, Piparia, Waghodia, Vadodara 391760, Gujarat, India
  • A K Seth Department of Pharmacy, Sumandeep Vidyapeeth University, Piparia, Waghodia, Vadodara 391760, Gujarat, India

Abstract

Objective: Development and validation of two simple, rapid, accurate and sensitive UV-spectrophotometric methods for simultaneous estimation of alogliptin benzoate (ALO) and metformin hydrochloride (MET) in bulk and tablet dosage form.

Methods: First method (Method A) is simultaneous equation method, which is based on the measurement of absorption at 224 nm and 237 nm for both ALO and MET, respectively. Second method (Method B) is an absorption ratio method, which is based on the measurement of absorption at 251 nm i.e. Iso-absorptive point of ALO and MET and 224 nm which is λmax of ALO.

Results: Both the drugs were found to be linear in the concentration range of 0.5-18 µg/ml and correlation co-efficient was found to be 0.9998 and 0.9992 for ALO and 0.9998 and 1 for MET at 224 nm and 237 nm, respectively for simultaneous equation method. For absorption ratio method, both the drugs were found to be linear in the concentration range of 0.5-18 µg/ml and correlation co-efficient was found to be 0.9998 and 0.9997 for ALO and 0.9998 and 0.9997 for MET at 224 nm and 251 nm, respectively. Recovery studies at 50, 100 and 150% levels were carried out to assess accuracy of the methods. Precision studies were also carried out and %RSD was found to be within the limit (% RSD<2). The percentage assay (Method A) was found to be 100.57±1.1367 and 101.24±1.0936 for ALO and MET, respectively. For Method B, percentage assay was found to be 101.46±0.7160 for ALO and 100.15±0.6953 for MET.

Conclusion: The developed methods were found to be simple, rapid, accurate and sensitive. Therefore, both the methods can be successfully applied for simultaneous determination of ALO and MET in tablet formulation.

 

Keywords: Alogliptin benzoate, Metformin hydrochloride, Simultaneous equation method, Absorption ratio method

Downloads

Download data is not yet available.

References

1. Christopher R, Karim A. Clinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes. Expert Rev Clin Pharmacol 2009;2(6):589-600.
2. White JR. Alogliptin for the treatment of type 2 diabetes. Drugs Today 2011;47(2):99-107.
3. The Merck Index, An encyclopedia of chemicals, drug, and biological. 13th edition. White House Station (NJ), Merck & Co Inc; 2001.
4. Martindale, The Complete Drug Reference. 36th edition. Vol. I. London (UK), Pharmaceutical Press (An Imprint of RPS Publishing); 2009.
5. Indian Pharmacopoeia, Government of India, Ministry of Health & Family Welfare. Vol. 2. Indian Pharmacopoeia Commission, Ghaziabad; 2007. p. 1358-60.
6. Tache F, David V, Farca A, Medvedovici A. HPLC-DAD determination of metformin in human plasma using derivatisation with p-nitrobenzoyl chloride in a biphasic system. Microchem J 2001;68(1):13-9.
7. Porta V, Schramm SG, Kano EK, Koono EE, Armando YP, Fukuda K, et al. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies. J Pharm Biomed Anal 2008;46(1):143-7.
8. Thangabalan B, Parvathareddy SS, Manohar BS. Method development and validation for metformin hydrochloride and alogliptin benzoate in bulk and pharmaceutical formulation by RP-HPLC method. Int J Innovative Pharm Sci Res 2014;2(7):1451-64.
9. Sri SG, Kumar AS, Saravanan J, Debnath M, Greeshma V, Sai KN. A new RP-HPLC method development for simultaneous estimation of Metformin and Alogliptin in bulk as well as in pharmaceutical formulation using PDA detector. World J Pharm Pharm Sci 2013;6(2):6720-43.
10. Kumar PA, Aruna G, Rajasekar K, Reddy JP. Analytical method development and validation of alogliptin and metformin tablet dosage form by RP-HPLC method. Int Bull Drug ReS 2013;3(5):58-68.
11. Yadav PJ, Kadam VN, Mohite SK. Development and validation of uv spectrophotometric method for alogliptin benzoate in bulk drug and tablet formulation. J Curr Pharm Res 2014;4(4):1286-90.
12. Chirag, Parle A. Development and validation of UV spectrophotometric method for simultaneous estimation of metformin hydrochloride and alogliptin benzoate in bulk drugs and combined dosage forms. Pharm Chem 2014;6(1):303-11.
13. Patel BP, Mashru RC. Sensitve and selective approaches for real time estimation of alogliptin benzoate and metformin hydrochloride in synthetic mixture. Int Bull Drug Res 2014;4(6):148-59.
14. Beckett AH, Stenlake JB. Practical Pharmaceutical Chemistry. 4th Edition. Part Two, New Delhi, CBS Publishers and distributors; 1997. p. 284-8.
Statistics
954 Views | 1555 Downloads
How to Cite
Sen, D. B., A. K. Sen, A. Zanwar, R. Balaraman, and A. K. Seth. “DETERMINATION OF ALOGLIPTIN BENZOATE AND METFORMIN HYDROCHLORIDE IN TABLET DOSAGE FORM BY SIMULTANEOUS EQUATION AND ABSORPTION RATIO METHOD”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 8, June 2015, pp. 380-3, https://innovareacademics.in/journals/index.php/ijpps/article/view/6953.
Section
Short Communication(s)